Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Northwest Neurological, PLLC
1776
mi
from 43215
Spokane, WA
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Northwest Neurological, PLLC
1776
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Hattiesburg Clinic
694
mi
from 43215
Hattiesburg, MS
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Hattiesburg Clinic
694
mi
from 43215
Hattiesburg, MS
Click here to add this to my saved trials
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
California Pacific Medical Center
2108
mi
from 43215
San Francisco, CA
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
California Pacific Medical Center
2108
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
ActivMed Practices & Research, Inc.
668
mi
from 43215
Portsmouth, NH
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
ActivMed Practices & Research, Inc.
668
mi
from 43215
Portsmouth, NH
Click here to add this to my saved trials
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
The Methodist Hospital Research Institute
995
mi
from 43215
Houston, TX
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
The Methodist Hospital Research Institute
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
AZ Klina
4043
mi
from 43215
Brasschaat,
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
AZ Klina
4043
mi
from 43215
Brasschaat,
Click here to add this to my saved trials
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System
2101
mi
from 43215
Palo Alto, CA
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System
2101
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
HealthPartners Riverside
624
mi
from 43215
Minneapolis, MN
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
HealthPartners Riverside
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
HealthPartners Neuroscience Center
617
mi
from 43215
Saint Paul, MN
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
A Phase II, Single Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and the Therapeutic Effectiveness of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
HealthPartners Neuroscience Center
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Translation of COPE for Publicly-Funded Home Care Clients and Their Families
Translation of COPE for Publicly-Funded Home Care Clients and Their Families
Status: Enrolling
Updated:  12/31/1969
UConn Center on Aging
545
mi
from 43215
Farmington, CT
Translation of COPE for Publicly-Funded Home Care Clients and Their Families
Translation of COPE for Publicly-Funded Home Care Clients and Their Families
Status: Enrolling
Updated: 12/31/1969
UConn Center on Aging
545
mi
from 43215
Farmington, CT
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
St. Joseph's Hospital and Medical Center
1661
mi
from 43215
Phoenix, AZ
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
St. Joseph's Hospital and Medical Center
1661
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Hoag Memorial Hospital Presbyterian
1958
mi
from 43215
Newport Beach, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Hoag Memorial Hospital Presbyterian
1958
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Pacific Research Network
1951
mi
from 43215
San Diego, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Pacific Research Network
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Galiz Research
984
mi
from 43215
Hialeah, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Galiz Research
984
mi
from 43215
Hialeah, FL
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Miami Jewish Health Systems
990
mi
from 43215
Miami, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Miami Jewish Health Systems
990
mi
from 43215
Miami, FL
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Emory University Brain Health Center
436
mi
from 43215
Atlanta, GA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Emory University Brain Health Center
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Disease Center
644
mi
from 43215
Quincy, MA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Disease Center
644
mi
from 43215
Quincy, MA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Steinberg Diagnostics
1755
mi
from 43215
Henderson, NV
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Steinberg Diagnostics
1755
mi
from 43215
Henderson, NV
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Wake Forest School of Medicine
312
mi
from 43215
Winston-Salem, NC
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Wake Forest School of Medicine
312
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Valley Medical Primary Care
64
mi
from 43215
Centerville, OH
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Valley Medical Primary Care
64
mi
from 43215
Centerville, OH
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
American Clinical Trials, LLC (Site 1216)
851
mi
from 43215
Oklahoma City, OK
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
American Clinical Trials, LLC (Site 1216)
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Research Institute
995
mi
from 43215
Houston, TX
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Research Institute
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
University of Washington Medicine
2006
mi
from 43215
Seattle, WA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
University of Washington Medicine
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Ray Dolby Brain Health Center
1982
mi
from 43215
San Francisco, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Ray Dolby Brain Health Center
1982
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Cherlin Research
2094
mi
from 43215
Los Gatos, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Cherlin Research
2094
mi
from 43215
Los Gatos, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Merritt Island Medical Research
817
mi
from 43215
Merritt Island, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Merritt Island Medical Research
817
mi
from 43215
Merritt Island, FL
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
D De La Vega MD Research Group
999
mi
from 43215
Miami, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
D De La Vega MD Research Group
999
mi
from 43215
Miami, FL
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Oklahoma Behavioral Health
851
mi
from 43215
Oklahoma City, OK
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Oklahoma Behavioral Health
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Sante Clinical Research
1137
mi
from 43215
Kerrville, TX
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Sante Clinical Research
1137
mi
from 43215
Kerrville, TX
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
University of Melbourne
mi
from 43215
Parkville,
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
University of Melbourne
mi
from 43215
Parkville,
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
California Research Foundation
1951
mi
from 43215
San Diego, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
California Research Foundation
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Syrentis Clinical Research
1960
mi
from 43215
Santa Ana, CA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Syrentis Clinical Research
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Clarity Clinical Research, LLC
414
mi
from 43215
Syracuse, NY
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Clarity Clinical Research, LLC
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Hospice of the Western Reserve
134
mi
from 43215
Cleveland, OH
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Hospice of the Western Reserve
134
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Overlake Internal Medicine Associates, PS
2000
mi
from 43215
Bellevue, WA
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Overlake Internal Medicine Associates, PS
2000
mi
from 43215
Bellevue, WA
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Adirondack Medical Research Center
535
mi
from 43215
Glens Falls, NY
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Adirondack Medical Research Center
535
mi
from 43215
Glens Falls, NY
Click here to add this to my saved trials
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated:  12/31/1969
Bioclinica
795
mi
from 43215
Orlando, FL
18F-AV-1451 Autopsy Study
A Clinico-Pathological Study of the Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
Status: Enrolling
Updated: 12/31/1969
Bioclinica
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Brain Sleep Clearance of Amyloid-Beta Peptides
Brain Sleep Clearance of Amyloid-Beta Peptides
Status: Enrolling
Updated:  12/31/1969
Bellevue Hospital Center
479
mi
from 43215
New York, NY
Brain Sleep Clearance of Amyloid-Beta Peptides
Brain Sleep Clearance of Amyloid-Beta Peptides
Status: Enrolling
Updated: 12/31/1969
Bellevue Hospital Center
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Brain Sleep Clearance of Amyloid-Beta Peptides
Brain Sleep Clearance of Amyloid-Beta Peptides
Status: Enrolling
Updated:  12/31/1969
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Brain Sleep Clearance of Amyloid-Beta Peptides
Brain Sleep Clearance of Amyloid-Beta Peptides
Status: Enrolling
Updated: 12/31/1969
NYU Langone Medical Center
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
948
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Miami Jewish Health Systems
990
mi
from 43215
Miami, FL
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Miami Jewish Health Systems
990
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2a Feasibility Study of T3D-959 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
New Hope Clinical Research
349
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc.
1964
mi
from 43215
Costa Mesa, CA
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
1964
mi
from 43215
Costa Mesa, CA
Click here to add this to my saved trials
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated:  12/31/1969
Neuro-Pain Medical Center
1987
mi
from 43215
Fresno, CA
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated: 12/31/1969
Neuro-Pain Medical Center
1987
mi
from 43215
Fresno, CA
Click here to add this to my saved trials
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated:  12/31/1969
Senior Clinical Trials, Inc.
1955
mi
from 43215
Laguna Hills, CA
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated: 12/31/1969
Senior Clinical Trials, Inc.
1955
mi
from 43215
Laguna Hills, CA
Click here to add this to my saved trials
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
A Phase 2a Multicenter, Randomized, Double-Blind, Parallel Group, 26-Week, Placebo-Controlled Study of SUVN-502 in Subjects With Moderate Alzheimer's Disease Currently Treated With Donepezil Hydrochloride and Memantine Hydrochloride
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
1975
mi
from 43215
Long Beach, CA
Click here to add this to my saved trials